Showing results (1661-1670 of 9,979) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|July 1, 1993
Reduction of allogeneic transplant morbidity by combining peripheral blood and bone marrow progenitor cellsJ Nemunaitis, V Albo, Z R Zeigler, et al.Leukemia & Lymphoma|September 1, 1993
Transplantation of autologous peripheral blood stem cells mobilized using GM-CSF for acute leukemia with myelofibrosisJ Mehta, R L Powles, V Shepherd, et al.Leukemia & Lymphoma|December 1, 1993
Clinical relevance of acute mixed-lineage leukemiasF Ferrara, L Del VecchioLeukemia & Lymphoma|December 1, 1993
Application of low-dose etoposide therapy for myelodysplastic syndromesK Ogata, T NomuraLeukemia & Lymphoma|November 1, 1993
Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patientsM Delain, J Y Cahn, E Racadot, et al.Leukemia & Lymphoma|January 1, 1993
Viral infections in leukemia and bone marrow transplant patientsJ R WingardLeukemia & Lymphoma|January 1, 1993
Chronic lymphocytic leukemia--correlation of response and survivalM J Keating, S O'Brien, L Robertson, et al.Leukemia & Lymphoma|January 1, 1993
Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangementsM Cole-Sinclair, L Foroni, F Wright, et al.Leukemia & Lymphoma|October 21, 2005
BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study GroupJ U Rüffer, V Ballova, J Glossmann, et al.Leukemia & Lymphoma|October 21, 2005
Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphomaJ M Vose, B K Link, M L Grossbard, et al.Pageof 998